Skip to content

Evaluation of a Oncology Day Care Unit Programme With Two Different Focuses

Integrative Oncology - Evaluation of a Oncology Day Care Unit Programme With Two Different Focuses

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04411251
Acronym
TK-Onko
Enrollment
107
Registered
2020-06-02
Start date
2020-07-14
Completion date
2022-05-01
Last updated
2023-06-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cancer

Keywords

Nature, Mind-Body Therapies, Mindfulness, Yoga, Meditation

Brief summary

The aim of this study is to investigate the effects of a nature-centred integrative oncology day care unit programme (outdoor concept) compared with an already established integrative oncology day care unit programme (indoor concept).

Interventions

BEHAVIORALNature-near integrative day care unit programme

Interventions based on the Mind Body Medicine in Integrative and Complementary Medicine (MICOM) programme

BEHAVIORALConventional integrative day care unit programme

Interventions based on the Mind Body Medicine in Integrative and Complementary Medicine (MICOM) programme

Sponsors

Charite University, Berlin, Germany
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
No

Inclusion criteria

\- cancer diagnosis

Exclusion criteria

* cognitive impairment that would interfere with questionnaire replies or the intervention * pregnancy or lactation * known serious mental illness * participation in another study

Design outcomes

Primary

MeasureTime frameDescription
Functional Assessment of Cancer Therapy - General (FACT-G)Change from date of inclusion (baseline) at 12 weeks and at 24 weeksAssessing full scale, range 0-108, higher score meaning a better outcome

Secondary

MeasureTime frameDescription
Functional Assessment of Cancer Therapy - Breast Cancer (FACT-B)Date of inclusion (baseline), after 12 weeks, after 24 weeksAssessing full scale, range 0-40, higher score meaning a better outcome
Functional Assessment of Cancer Therapy: Fatigue (FACT-F)Date of inclusion (baseline), after 12 weeks, after 24 weeksAssessing full scale, range 0-52, higher score meaning a better outcome
WHO-Five Well-Being Index (WHO-5)Date of inclusion (baseline), after 12 weeks, after 24 weeksAssessing full scale, range 0-25, higher score meaning a better outcome
Perceived Benefits of Nature Questionnaire (PBNQ)Date of inclusion (baseline), after 12 weeks, after 24 weeksmean score of the 11 items, range 1-7, lower score meaning a better outcome
Perceived Stress Scale (PSS-10)Date of inclusion (baseline), after 12 weeks, after 24 weeksAssessing full scale, range 0-40, lower score meaning a better outcome
Hospital Anxiety and Depression Scale (HADS)Date of inclusion (baseline), after 12 weeks, after 24 weeksAssessing full scale, range 0-42, lower score meaning a better outcome
Flourishing Scale (FS-D)Date of inclusion (baseline), after 12 weeks, after 24 weeksAssessing full scale, range 8-56, higher score meaning a better outcome
Freiburg Mindfulness Inventory (FMI)Date of inclusion (baseline), after 12 weeks, after 24 weeksAssessing full scale, range 0-56, higher score meaning a better outcome
Insomnia Severity Index (ISI)Date of inclusion (baseline), after 12 weeks, after 24 weeksAssessing full scale, range 0-28, lower score meaning a better outcome
Self-Compassion Scale (SCS-D)Date of inclusion (baseline), after 12 weeks, after 24 weeksmean score of 12 items, range 1-5, higher score meaning a better outcome
Behavioral questions: alcohol consumptionDate of inclusion (baseline), after 12 weeks, after 24 weeksNumber of alcoholic beverages on average per week in the last month
Behavioral questions: relaxationDate of inclusion (baseline), after 12 weeks, after 24 weeksRelaxation behavior on average per week in the last month in minutes
Behavioral questions: cigarettesDate of inclusion (baseline), after 12 weeks, after 24 weeksNumber of cigarettes on average per week in the last month in minutes
Sociodemographic MeasurementsDate of inclusion (baseline)Age, gender, education level, household income, employment status, marital status, complete family history, current and previous diseases and co-morbidities, current medication intake
Body weightDate of inclusion (baseline), after 12 weeks, after 24 weekskg
Expectation questionsDate of inclusion (baseline)For intervention 1 and intervention 2 on a 5-point likert scale from 1 (nothing at all) to 5 (very strong)
Behavioral questions: sportDate of inclusion (baseline), after 12 weeks, after 24 weeksSports behavior on average per week in the last month in minutes
Self-Efficacy Scale - Short Form (ASKU)Date of inclusion (baseline), after 12 weeks, after 24 weeksmean score of the 3 items, range 1-5

Other

MeasureTime frameDescription
Qualitative interviews12 weeks and 24 weeks after inclusionQualitative assessment will be carried out in qualitative interviews in 20 patients participating in the study. The interviews will be recorded, transcribed and analyzed with qualitative content analysis.

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026